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Abstract
Introduction:  Patients  undergoing  hematopoietic  stem  cell  transplantation  receive  high  doses
of chemotherapy  and  radiotherapy,  which  cause  severe  immunosuppression.
Objective:  To  report  an  oral  disease  management  protocol  before  and  after  hematopoietic  stem
cell transplantation.
Methods:  A  prospective  study  was  carried  out  with  65  patients  aged  >  18  years,  with  hemato-
logical diseases,  who  were  allocated  into  two  groups:  A  (allogeneic  transplant,  34  patients);  B
(autologous  transplant,  31  patients).  A  total  of  three  dental  status  assessments  were  performed:
in the  pre-transplantation  period  (moment  1),  one  week  after  stem  cell  infusion  (moment  2),
and 100  days  after  transplantation  (moment  3).  In  each  moment,  oral  changes  were  assigned
scores and  classiﬁed  as  mild,  moderate,  and  severe  risks.
Results:  The  most  frequent  pathological  conditions  were  gingivitis,  pericoronitis  in  the  third
molar region,  and  ulcers  at  the  third  moment  assessments.  However,  at  moments  2  and  3,
the most  common  disease  was  mucositis  associated  with  toxicity  from  the  drugs  used  in  the
immunosuppression.
Conclusion:  Mucositis  accounted  for  the  increased  score  and  potential  risk  of  clinical
complications.  Gingivitis,  ulcers,  and  pericoronitis  were  other  changes  identiﬁed  as  potential
risk factors  for  clinical  complications.
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Elsevier Editora  Ltda.  All  rights  reserved.
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PALAVRAS-CHAVE
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Oncologia
Alterac¸ões  orais  em  indivíduos  submetidos  à  transplante  de  células  hematopoiéticas
Resumo
Introduc¸ão:  Pacientes  submetidos  a  transplante  de  células  hematopoiéticas  recebem  altas
doses de  quimioterapia  e  radioterapia  que  podem  causar  imunossupressão  e  doenc¸as  orais
graves.
Objetivo:  Apresentar  um  protocolo  de  avaliac¸ão  de  doenc¸as  orais  antes  e  após  transplante  de
células hematopoiéticas.
Método:  Estudo  clínico  prospectivo  de  65  pacientes  com  idade  acima  de  18  anos,  com  doenc¸as
hematológicas  submetidas  a  transplante  de  células  hematopoiéticas,  divididos  em  dois  gru-
pos: A  (transplante  alogênico,  34  pacientes)  e  B  (transplante  autólogo).  Foram  realizadas  três
avaliac¸ões odontológicas:  período  antes  do  transplante  (momento  1),  uma  semana  (momento
2) e  100  dias  após  o  transplante  (momento  3).  Em  cada  momento  as  alterac¸ões  orais  foram
pontuadas  e  classiﬁcadas  como  leve,  moderada  e  grave.
Resultados:  As  alterac¸ões  orais  mais  frequentes  foram:  gengivite,  pericoronite  do  terceiro
molar e  úlceras.  Entretanto  nos  momentos  dois  e  três  a  principal  doenc¸a  foi  a  mucosite  associada
a toxicidades  das  drogas  usadas  na  imunossupressão.
Conclusão:  Mucosite  foi  principal  alterac¸ão,  com  a  pontuac¸ão  mais  alta  e  com  maior  risco  de
complicac¸ões. Gengivites,  úlceras  e  pericoronites  foram  outras  alterac¸ões  com  risco  menor  de
complicac¸ões.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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longitudinal  temporal  cohort  study,  with  a  data  collectionntroduction
ematopoietic  stem  cell  transplantation  (HSCT)  is  the
eplacement  of  a  diseased  or  deﬁcient  bone  marrow  by
ormal  cells,  with  the  aim  of  reconstituting  the  marrow
nd  providing  immune  system  control.  It  is  classiﬁed  as
utologous  when  bone  marrow  precursor  cells  come  from
he  patient,  and  as  allogeneic,  when  the  cells  come  from
nother  person  (donor),  who  may  or  may  not  be  related  to
he  recipient.1,2
Patients  who  will  undergo  HSCT  are  submitted  to  high
oses  of  chemotherapy  and  radiation  therapy  to  eradicate
he  underlying  disease,  which  induces  an  intense  immuno-
uppression  period  known  as  the  conditioning  phase.  This
eriod  is  characterized  by  possible  tissue  damage  and  infec-
ions  due  to  immunosuppressive  drug  toxicity.3--5
Mucositis  is  one  of  the  most  common  oral  tissue  lesions
escribed  in  these  immunosuppressed  patients,  caused  by
he  toxicity  of  these  drugs;  it  results  in  a  fragility  of  the  oral
ucosa  with  decreased  numbers  of  basal  cells,  and  even  the
nset  of  ulcerations.6--8 It  is  considered  the  most  important
ral  cavity  complication  in  patients  undergoing  bone  marrow
uppression,  and  is  also  the  most  common,  with  an  incidence
f  90%.9,10 Kolbinson  et  al.11 described  early  changes  in  the
ral  mucosa  such  as  erythema,  ulceration,  and  epithelial
seudomembrane  formation  that  appear  between  ﬁve  and
even  days  after  the  onset  of  chemotherapy  and  improve
fter  three  weeks.
These  lesions  represent  a  signiﬁcant  risk  factor  for  sys-
emic  infections,  particularly  in  patients  with  neutropenia,
nd  20--50%  of  cases  of  septicemia  originate  from  the  oral
avity.12--14 For  Puyal  et  al.,10 Köstler  et  al.,15 and  Yama-
ata  et  al.,16 the  rates  of  occurrence  of  oral  lesions  varied,
p
s
tepending  on  the  type  of  underlying  disease,  the  treatment
sed  and  oral  status  before  conditioning  for  transplantation,
nd  reﬂected  mainly  pre-existing  oral  conditions.
Lesions  such  as  root  fragments,  periodontal  pockets,
eriapical  lesions,  and  removable  dentures  are  considered
eservoirs  of  opportunistic  pathogens  that  can  trigger  infec-
ions  during  immunosuppression.9,17--19
These  reports  indicate  that  the  prevention  of  oral  dis-
ase  prior  to  HSCT  is  extremely  important  and  that  oral
iseases  should  be  treated  before  transplantation  to  elim-
nate  potential  risk  factors  for  systemic  infections.7,20--22
reizen  et  al.22 reported  that  30--50%  of  patients  under-
oing  chemotherapy  for  oncologic  treatment  develop  oral
lterations  or  lesions,  and  that  incidence  can  be  signiﬁcantly
educed  by  prior  oral  intervention.  However,  we  found  few
tudies  in  the  literature,  except  those  for  mucositis,  which
ttempted  to  quantify  oral  alterations  that  occur  in  patients
ndergoing  bone  marrow  transplantation.  When  the  authors,
pplied  a  score  to  the  condition,  they  eliminated  the  subjec-
ive  nature  of  the  potential  of  these  alterations  for  clinical
omplications.3,7,8,23--30 Thus,  the  objective  of  this  research
as  to  develop  a  standardized  method  for  the  quantitative
valuation  of  alterations  or  lesions  of  the  oral  cavity,  and  to
dentify  the  potential  for  clinical  complications  in  patients
ubmitted  to  HSCT.
ethods
he  present  study  was  a  clinical,  prospective,  six-montheriod  of  24  months,  performed  at  a  referral  hospital.  The
tudy  was  approved  by  the  local  research  Ethics  Commit-
ee  (No.  39/2007).  A  total  of  65  patients  aged  >  18  years,  of
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Table  1  Data  standardization  form  with  scores  related  to
changes  in  the  oral  cavity.
Caries:
No  caries:  (  )
Presence  of  1--5  decayed  teeth:  1  point  (  )
Presence  of  5--10  decayed  teeth:  2  points  (  )
Presence  of  10--15  decayed  teeth:  3  points  ( )
Presence  of  more  than  15  decayed  teeth:  4  points  (  )
Gingival  pockets:  points  per  tooth,  maximum  of  15  points:
Normal  (absence  of  bleeding  at  periodontal  probing):  (  )
Gingival  pockets  of  3--5  mm:  1  point  (  )
Gingival  pockets  of  5--8  mm:  2  points  (  )
Gingival  pockets  >  8  mm:  3  points  (  )
Tooth  mobility: Classiﬁcation  of  periodontal  diseases  and
conditions,  Armitage,  1999:  points  per  tooth,  maximum
of 15  points:
No  tooth  mobility:  (  )
Mild  (1--2  mm  of  clinical  attachment  loss):  1  point  (  )
Moderate  (3--4  mm  of  clinical  attachment  loss):  2  points  (  )
Severe (>5  mm):  3  points  (  )
Exodontics: points  per  tooth,  maximum  of  10  points:
Absence  of  teeth  with  extraction  indication:  (  )
Radicular  remains:  1  point  (  )
Semi-impacted/impacted  third  molar,  with  history  of
pericoronitis:  1  point  (  )
Prostheses:
No  prostheses:  (  )
Full  dentures:  1  point  (  )
Removable  partial  dentures:  1  point  (  )
Permanent  dentures:  1  point  (  )
Dentures  on  implants:  1  point  (  )
Orthodontic  appliances:
No  orthodontic  appliances:  (  )
Presence  of  orthodontic  appliances:  1  point  (  )
Oral lesions:  points  per  oral  lesion,  maximum  of  10  points.
No oral  lesions:  (  )
Presence  of  oral  lesions:  1  point  (  )
Mucositis: WHO  classiﬁcation:
No  mucositis:  (  )
Mucositis  grade  I:  5  points  (  )
Mucositis  grade  II:  10  points  (  )
Mucositis  grade  III:  15  points  (  )
Mucositis  grade  IV:  20  points  (  )
Infections:
No infections:  (  )
Presence  of  bacterial  infection:  10  points  (  )
Presence  of  viral  infection:  10  points  (  )
s
cPatients  undergoing  hematopoietic  stem  cell  transplantation
both  genders,  with  or  without  hematological  malignancies,
who  underwent  HSCT  and  immunosuppression  in  the  above-
mentioned  period  were  included.  Patients  were  grouped
according  to  the  type  of  HSCT:  group  A  (allogeneic),  34
patients;  and  group  B  (autologous),  31  patients.  Initially,
all  answered  a  questionnaire,  which  contained  information
on  oral  health  and  oral  hygiene  habits.  Subsequently,  the
patients  were  evaluated  according  to  the  status  of  the  oral
cavity  at  20  days,  on  average,  before  conditioning  and  HSCT
(moment  1).  The  second  evaluation  was  carried  out  in  the
ﬁrst  week  after  transplantation  (moment  2),  and  the  last
evaluation  100  days  after  HSCT  (moment  3).
At  the  evaluation  moments  (1,  2,  and  3)  scores  were  given
to  the  different  alterations  found  in  the  oral  cavity,  accord-
ing  to  the  proposed  dental  standardization  (Table  1).  The
score  given  to  the  oral  alterations  was  based  on  previous
work,  which  gave  greater  or  lesser  degree  of  importance  to
the  histopathological  alterations  of  the  oral  cavity.3,7--10,14,24
The  risk  classiﬁcation  and  degrees  of  toxicity  were  based  on
the  work  of  Porak,14 Dreizen  et  al.,22 and  Parulekan  et  al.24
In  moment  1,  patients  were  classiﬁed  according  to  the  risk
for  complications:  mild  (up  to  15  points),  moderate  (16--30
points),  and  severe  (31--50  points)  risk.  In  moments  2  and  3,
the  degrees  of  toxicity  were  classiﬁed  as  follows:  mild  (15
points),  moderate  (16--30  points),  and  severe  (31--50  points;
Table  1).
Evaluation  results  were  compared  among  themselves  and
between  groups.  For  the  variables  gender,  age,  disease,
drugs  for  conditioning,  cell  source,  and  type  of  transplan-
tation,  the  chi-squared  or  Fisher’s  exact  test  were  used  for
comparison  of  the  groups.  For  the  variables  dental  caries,
gingival  pockets,  tooth  mobility,  tooth  extractions,  den-
tures,  orthodontic  devices,  oral  lesions,  bacterial,  viral,
fungal  infections,  and  mucositis,  the  Mann--Whitney  test
was  used.  Comparison  between  groups  at  each  evalua-
tion  was  performed  using  Friedman’s  test  and  comparison
of  moments  within  each  group  was  performed  using
Fisher’s  test.  The  level  of  signiﬁcance  was  set  at  5%
(p  <  0.05).
Results
After  the  assessment  of  oral  alterations,  the  classiﬁcation  of
risks  and  toxicity  of  patients  was  performed  by  summation  of
the  scores  (Tables  2--4).  In  the  ﬁrst  assessment,  before  con-
ditioning,  most  patients  received  a  mild  risk  classiﬁcation
in  both  groups.  The  only  patient  classiﬁed  as  having  moder-
ate  risk  had  gingival  pockets  >  6  mm  and  tooth  mobility;  that
patient’s  score  was  >  16  (Table  5).
In  the  second  evaluation,  of  the  34  assessed  patients  in
group  A,  18  had  mild  toxicity,  15  moderate,  and  one  patient
had  severe  toxicity.  In  group  B,  of  the  31  patients  assessed,
19  had  mild  toxicity,  11  moderate,  and  one  patient  had
severe  toxicity  (Table  6).  As  it  can  be  observed,  the  risk
and  toxicity  classiﬁcation  in  both  groups  were  performed
according  to  the  presence  of  mucositis  and  its  degree  of
severity.In  the  third  evaluation,  as  a  result  of  deaths,  28  patients
were  assessed  in  group  A  and  30  patients  in  group  B.  All  but
one  patient  had  mild  toxicity  in  this  assessment,  and  one
patient  persisted  with  severe  toxicity  (Table  7).
i
(
w
sPresence  of  fungal  infection:  10  points  (  )
No  statistical  differences  were  observed  regarding  the
cores  in  both  groups  A  and  B,  for  the  variables  dental
aries,  gingival  pockets,  tooth  mobility,  tooth  extraction
ndication,  dentures,  and  orthodontics  in  the  three  moments
Tables  2  and  3).  Comparing  the  moments  of  assessment
ithin  the  groups,  it  was  observed  that  there  was  no
tatistically  signiﬁcant  increase  in  oral  mucosal  lesions
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Table  2  Distribution  of  oral  abnormalities  observed  in  subjects  from  group  A.
Oral  alterations  Moment  1
n  =  34
Moment  2
n  =  34
Moment  3
n  =  28
Tooth  caries  n  =  19  (59.4%)  n  =  19  (59.4%)  n  =  18  (66.7%)
Gingival pockets  n  =  8  (25.0%)  n  =  8  (25.8%)  n  =  7  (25.9%)
Mobility n  =  5  (15.6%)  n  =  6  (18.8%)  n  =  5  (18.5%)
Tooth loss  n  =  10  (31.2%)  n  =  9  (28.1)  n  =  8  (29.6%)
Prostheses n  =  14  (41.2%)  n  =  14  (41.2%)  n  =  10  (35.7%)
Orthodontics 0  0  0
Oral lesions  n  =  8  (23.5%)  n  =  16  (47.1%)  n  =  7  (53.6%)
Infections -- -- n  =  2  (7.2%)
Mucositis 0  n  =  34  (100%) 0
Table  3  Distribution  of  oral  abnormalities  observed  in  subjects  from  group  B.
Oral  alterations  Moment  1
n  =  31
Moment  2
n  =  31
Moment  3
n  =  30
Tooth  caries 8  (26.7%) 8  (26.7%) 7  (24.1%)
Gingival pockets 8  (26.6%) 8  (26.6%) 8  (27.6)
Mobility 9  (30%) 9  (30%) 9  (31.0%)
Tooth loss 9  (30%) 9  (30%) 8  (27.6%)
Prostheses 18  (54.8%)  18  (54.8%)  18  (54.8%)
Orthodontics 2  (6.7%)  2  (6.7%)  2  (6.7%)
Oral lesions  5  (16.1%)  7  (22.6%)  5  (16.7%)
Infections 0  0  0
Mucositis 0  31  (100%)  0
Table  4  Patient  distribution  by  group  and  grade  of
mucositis.
Grade  of  mucositis  Group
A  B
n  %  n  %
I  7  20.6  8  25.8
II 9  26.5  10  32.3
III 10  29.4  9  29.0
IV 8  23.5  4  12.9
Total 34  100.0  31  100.0
Table  5  Distribution  of  patients  by  transplantation  group
and risk  at  moment  1,  p  =  0.34.
Risk  at  moment  1
Mild  Moderate  Total
Group  n  %  n  %  n  %
A  33  97.1  1  2.9  34  100.0
B 31  100.0  --  0.0  31  100.0
Table  6  Distribution  of  patients  by  transplantation  group
and toxicity  at  moment  2.
Grades  of  toxicity  at  moment  2
Group  Mild  Moderate  Severe
n  %  n  %  n  %
A  18  52.9  15  44.2  1  2.9
B 19  61.3  11  35.5  1  3.2
2 = 0.50; p = 0.78.
Table  7  Distribution  of  patients  according  to  group  and
toxicity  at  moment  3.
Grades  of  toxicity  at  moment  3
Group  Mild  Moderate  Severe
n  %  n  %  n  %
A  27  96.4  --  0.0  1  3.6
B 30  100.0  --  0.0  --  0.0
2 = 1.09; p = 0.29.
Total 64  98.5  1  1.5  65  100.0
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over  time  within  group  A  (p  =  0.039).  However,  a  statisti-
cally  signiﬁcant  difference  was  observed  when  comparing
moment  2  of  groups  A  versus  B,  as  mucositis  was  observed
in  100%  of  individuals  in  both  groups  at  these  moments
(Tables  2  and  3).
Discussion
HSCT  is  a  widely  used  therapeutic  technique,  aiming  to  cure
oncologic  patients  and  to  provide  disease  control.1 How-
ever,  conditioning  with  chemotherapy  drugs  can  result  in
several  oral  and  systemic  alterations  in  immunosuppressed
patients.3--6 These  manifestations  can  increase  the  length  of
hospital  stay,  increase  treatment  costs,  and  directly  affect
the  quality  and  quantity  of  life  of  these  patients.25
In  the  autologous  HSCT,  comorbidities  occur  most  often
due  to  the  underlying  disease  activity,  whereas  in  allo-
geneic  HSCT,  they  are  due  to  systemic  complications  and  the
graft  versus  host  reaction  itself.1,2,17,30 The  intense  immuno-
suppression  predisposes  transplanted  patients  to  severe
infections  that  can  occur  at  any  time  of  transplantation,  can
be  caused  by  different  etiological  agents  such  as  bacteria,
fungi,  viruses,  or  parasites.13,21
Establishing  risk  factors  by  assessing  the  status  of  the
oral  cavity  and  systemic  complications  of  HSCT,  and  by
assigning  scores  to  the  alterations  at  different  times  of  the
clinical  follow-up  of  patients  submitted  to  immunoexpres-
sion  might  facilitate  the  identiﬁcation  of  individuals  who
would  potentially  have  more  clinical  complications.8,16 A
quantitative  analysis  using  scores  eliminates  the  subjec-
tive  nature  of  the  observations.24 In  the  present  study,  the
development  and  utilization  of  scores  for  oral  alterations
were  based  on  previous  studies  that  sought  to  associate,
through  scores  or  degrees  of  intensity,  what  changes  or
oral  diseases  associated  with  transplantation  would,  in  the-
ory,  have  greater  potential  to  be  associated  with  clinical
complications.14,16,19,22,24
The  creation  of  tables  and  dental  records  was  made  based
on  the  following  variables:  dental  caries,  gingival  pockets,
tooth  mobility,  root  fragments,  tooth  extraction  indication,
use  of  dentures,  orthodontic  devices,  and  oral  lesions.
Alterations  also  included  the  speciﬁc  complications  of
HSCT,  such  as  the  occurrence  of  bacterial,  fungal  and  viral
infections,  as  well  as  the  degree  of  mucositis.8,14,22
With  respect  to  dental  caries,  the  present  data  and  those
in  the  literature  showed  no  signiﬁcant  increase  in  new  dental
caries  in  patients  in  the  post-transplantation  period  and,
as  they  are  not  relevant  to  HSCT  complications,  they  have
minimal  score.
The  gingival  status  and  tooth  mobility  have  a  potential
risk  factor  for  complications,  especially  periodontal  pockets
greater  than  6  mm.26,27 Gingival  pockets  of  this  size  favor
greater  accumulation  of  bacteria  and  necrotic  tissue,  and
increase  the  risks  for  dental  and  oral  disease;  therefore,
they  received  scores  of  up  to  15,  with  intermediate  values
between  dental  caries  and  mucositis.
In  both  groups  of  the  present  study,  only  one  patient  had
larger  gingival  pockets,  ranging  from  5  mm  to  8  mm,  and  was
classiﬁed  at  moment  1  as  moderate  risk  and  at  moments  2
and  3  as  severe  toxicity,  due  to  the  presence  of  deep  gingival
pockets.
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Another  common  observation,  in  approximately  80%  of
he  patients,  was  gingival  hyperemia,  probably  due  to  toxic
eactions  to  drugs  used  during  conditioning.  Another  likely
ause  is  oral  mucosa  sensitization  due  to  antiseptic  mouth-
ash  (chlorhexidine)  used  in  oral  hygiene.  Patients  do  not
rush  their  teeth  for  fear  that  trauma  caused  by  the  brush
an  cause  bleeding,  due  to  thrombocytopenia.
However,  the  lack  of  brushing  can  result  in  an  increase
n  bacterial  plaque,  causing  gingivitis,  such  as  that  seen  in
ndividuals  at  moment  2  in  both  groups,  with  a  consequently
reater  risk  of  bleeding.  When  there  is  gingival  inﬂamma-
ion,  plaque  can  form  more  rapidly  in  those  sites  than  in
on-inﬂamed  ones  and  thus,  mouthwash  would  be  less  effec-
ive  for  oral  hygiene.  However,  in  the  present  sample,  these
lterations  were  barely  observed,  which  was  attributed  to
ore  effective  actions  before  transplantation  by  the  treat-
ng  institution.1,2,10,16,17
Findings  such  as  tooth  extractions  and  semi-impacted
hird  molars  with  a  history  of  pericoronitis  are  mentioned  in
he  literature  as  having  little  potential  as  source  of  oppor-
unistic  pathogens  and,  as  they  were  seldom  observed,  they
ere  not  scored.21--23
Semi-impacted  third  molars  were  observed  in  eight
atients  from  group  A  and  nine  from  group  B.  At  moment
,  together  with  mucositis  lesions,  there  was  formation  of
laque  and  gingiva  overlying  the  tooth.  For  this  type  of  ﬁnd-
ng,  and  for  prostheses  and  orthodontic  devices,  1  point  was
cored.  Shulman  et  al.28 reported  that  orthodontic  devices
nd  dentures  are  risk  factors  for  stomatitis.
Even  with  the  knowledge  of  this  report  of  possible  health
isks  for  individuals  wearing  prostheses,  it  was  not  pos-
ible  to  establish  statistically  signiﬁcant  data  correlating
hem  with  oral  alterations.29 But  since  we  knew  that  the
ral  cavity  is  the  gateway  of  infections  in  patients  under-
oing  immunosuppression  for  bone  marrow  transplantation
nd  that  the  use  of  orthodontic  devices  and  dentures  can
otentiate  them,  we  asked  our  patients  not  to  wear  them,
f  possible.21 These  recommendations  were  made  before  the
rst  evaluation,  and  were  the  reasons  for  the  paucity  of
lterations  at  moment  1.  Although  that  was  not  the  purpose
f  this  study,  we  demonstrated  the  importance  of  prevention
nd  treatment  of  oral  diseases  to  lessen  the  risk  of  clinical
omplications  in  immunosuppressed  individuals.8,21 This  was
lso  the  opinion  of  Sonis  and  Kuns,23 who  showed  a  decrease
n  these  complications  when  such  care  was  performed.
Some  non-infectious  oral  lesions,  such  as  oral  leuko-
lakia,  gingival  hyperplasia,  and  others  that  are  seldom
escribed  by  other  authors,  also  infrequently  were  observed
y  the  present  authors.  Oral  lesions  similar  to  hemorrhagic
esions  that  were  difﬁcult  to  characterize,  but  did  not  evoke
linical  complaints  were  observed  in  17  patients  from  group
 and  eight  patients  from  group  B  at  moment  2,  caused  per-
aps  by  thrombocytopenia;  these  were  resolved  in  moment
.
The  literature  documents  that  mucositis  is  unquestion-
bly  the  oral  alteration  that  is  the  main  risk  factor  for
he  systemic  infections  that  occur  in  between  20%  and  50%
f  HSCT  patients,  most  prevalent  in  those  with  associated
eutropenia.3,5--10,19--21 The  intensity  of  mucositis  can  vary
epending  on  the  underlying  disease  and  the  type  of  trans-
lantation,  as  well  as  the  oral  status  before  and  during
mmunosuppression.11,14,15
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In  the  present  study,  the  incidence  of  mucositis  was  100%
n  the  second  evaluation,  at  moment  2,  for  both  group  A
nd  group  B  patients.  The  risk  association  of  moment  2  and
ucositis  was  signiﬁcant.  Both  groups  showed  an  association
f  the  risk  classiﬁcation  and/or  toxicity  (mild,  moderate,
evere,  and  very  severe)  with  the  onset  of  mucositis  and
egrees  of  intensity.  Most  patients  were  classiﬁed  as  having
ild  risk,  but  those  who  developed  mucositis  were  classiﬁed
s  having  moderate  or  severe  risk.
These  patients  also  had  oral  lesions,  more  often  on  the
ongue  and  labial  mucosa,  characterized  as  erythema  of  the
ral  mucosa,  lichen  planus,  generalized  erosions,  ulcera-
ions,  and  xerostomia.30
Some  authors  reported  that  this  is  due  to  low  oral  food
ntake,  because  of  pain  caused  by  these  lesions.18,21,25 In
he  present  study,  this  observation  was  more  evident,  as
5  patients  from  group  B  required  the  introduction  of  par-
nteral  nutrition.  In  this  group  of  patients,  the  authors
bserved  dysphagia,  anorexia,  and  rapid  weight  loss  soon
fter  transplantation,  as  early  as  moment  2  of  the  evalua-
ion.
We  did  not  observe  other  infections,  such  as  those  caused
y  anaerobic  organisms  in  our  study  probably  due  to  preven-
ive  measures  with  oral  ﬂuconazole  and  nystatin,  as  well
s  the  use  of  antiseptic  mouthwash,  which  are  a  standard
rocedure  in  all  patients  undergoing  HSCT.10,14,15
Undoubtedly,  the  most  feared  complication  of  bone
arrow  transplantation  is  death,  that  occurs  in  15--20%
f  allogeneic  transplantations  and  in  5%  of  autologous
ransplantations.  Is  this  related  to  oral  alterations?  Death
ccurred  in  seven  of  the  present  patients,  between  moments
 and  3  after  transplantation.  One  of  the  deaths  occurred
n  group  B,  from  multiple-organ  failure  and  veno-occlusive
isease.  In  group  A,  six  patients  died.  Of  these,  four  died
ue  to  disease  recurrence,  one  patient  died  due  to  pneu-
onia  and  respiratory  failure,  and  one  patient  due  to  acute
ost-versus-graft  disease  and  sepsis.  In  none  of  them  were
he  causes  associated  with  oral  disease.  Although  mucositis
s  the  main  alteration  responsible  for  the  increase  in  clin-
cal  complications,  especially  infectious  ones  associated  to
onditioning  toxicity,  such  lesions  were  not  seen  in  these
atients  at  the  time  of  death,  perhaps  due  to  the  dra-
atic  moment  experienced  by  patients  and  the  medical
taff.
onclusion
e  afﬁrm  that  mucositis  is  the  oral  cavity  alteration  of
reatest  concern  as  a  potential  risk  for  complications  in
mmunosuppressed  patients.  Other  lesions,  such  as  gingivitis
nd  third-molar  pericoronitis,  considered  as  low-risk  indica-
ors  in  this  study  were  also  less  relevant.  This  alterations
ecame  more  evident  when  the  mild,  moderate  and  severe
isk  and  toxicity  scores  were  used  to  assess  the  clinical
omplications  in  immunossupressed  individuals.onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
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